Qualigen Therapeutics, Inc.

0.72 USD
-0.02 (-2.56%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Qualigen Therapeutics, Inc. stock is down -1.36% since 30 days ago. The next earnings date is Apr 30, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 8 December’s closed higher than November.

About Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc. develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers.